Back to search

Clinical relevance of immunologic phenotype in diffuse large cell lymphoma

Data up to Jan 2025

Published1984
Citations92
References31

Total Citations Per Year

Abstract

References (31)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Report of the Committee on Hodgkin's Disease Staging Classification.

1971 • 4,212 citations

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

1965 • 3,333 citations

Atlas of tumor pathology

1968 • 3,075 citations

Two populations of Ia-like molecules on a human B cell line.

1980 • 1,112 citations

Characterization of a human B lymphocyte-specific antigen.

1980 • 1,098 citations

Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man

1981 • 871 citations

Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma

1976 • 837 citations

Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells.

1981 • 576 citations

Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems.

1981 • 545 citations

ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE

1975 • 483 citations

Diffuse Aggressive Lymphomas: Increased Survival After Alternating Flexible Sequences of ProMACE and MOPP Chemotherapy

1983 • 384 citations

Studies of a human T lymphocyte antigen recognized by a monoclonal antibody.

1981 • 349 citations

Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).

1983 • 343 citations

A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation.

1981 • 281 citations

Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.

1981 • 224 citations

Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy

1977 • 219 citations

Lymphoid Blast Crises of Chronic Myelogenous Leukemia Represent Stages in the Development of B-Cell Precursors

1983 • 215 citations

Combination Chemotherapy of Advanced Diffuse Histiocytic Lymphoma with the Six-Drug COP-BLAM Regimen

1982 • 189 citations

Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas.

1977 • 169 citations

Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphoma

1981 • 163 citations

Immunologic Phenotype in 30 Patients with Diffuse Large-Cell Lymphoma

1980 • 156 citations

Clinical Relevance of the Histopathological Subclassification of Diffuse “Histiocytic” Lymphoma

1978 • 149 citations

A single monoclonal antibody identifies T-cell lineage of childhood lymphoid malignancies

1983 • 149 citations

Clinical Utility of Lymphocyte Surface Markers Combined with the Lukes-Collins Histologic Classification in Adult Lymphoma

1979 • 130 citations

Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.

1983 • 116 citations

Factors Predicting for Response and Survival in Adults With Advanced Non-Hodgkin's Lymphoma

1978 • 100 citations

Cell surface phenotype in lymphoproliferative disease

1980 • 73 citations

Surface marker and histopathologic correlation with long-term survival in advanced large-cell non-Hodgkin's lymphoma

1981 • 43 citations

Resistance of tumor-bearing mice to a second tumor challenge.

1983 • 34 citations

Autologous bone marrow transplantation in T-cell malignancies: A case report involving in vitro treatment of marrow with a pan-T-cell monoclonal antibody

1982 • 21 citations

Cited By (0)

No citing papers found in database

Clinical relevance of immunologic phenotype in diffuse large cell lymphoma (1984) – Blood | Metascience Observatory Explorer